Type 2 DM is a itself chronic inflammatory condition, characterized by increased differentiation of monocytes into macrophages (41); however, on the other hand, the chronic inflammatory state promotes insulin resistance and the development of type 2 DM through altered signaling of inflammatory molecules (i.e., IL-6) in the liver (41). Here, IL6 is linked to Insulin resistance.